generics

High Court Weighs Drug Companies’ Generics Policy
WASHINGTON (AP) — Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny consumers price declines that can top 90 percent...